Bassier Zadran Daniel Wainwright Dr Yvonne Bury Dr Saimir Luli Rachel Howarth et al. | Impact of retrotransposon protein L1 ORF1p expression on oncogenic pathways in hepatocellular carcinoma: the role of cytoplasmic PIN1 upregulation | 2023 |
|
Dr Daniel Geh Robyn Watson Gourab Sen Jeremy French John Hammond et al. | COVID-19 and liver cancer: Lost patients and larger tumours | 2022 |
|
Nicola Dyson Dr Nicole Kattner Minna Honkanen-Scott Bethany Hunter Jennifer Doyle et al. | Development and Application of a Semi quantitative Scoring Method for Ultrastructural Assessment of Acute Stress in Pancreatic Islets | 2022 |
|
Dr Sam Tingle Dr Emily Thompson Lucy Bates Dr Ibrahim Ibrahim Dr Olivier Govaere et al. | Pharmacological testing of therapeutics using normothermic machine perfusion: A pilot study of 2,4-dinitrophenol delivery to steatotic human livers | 2022 |
|
Dr Praveen Dhondurao Sudhindar Daniel Wainwright Dr Santu Saha Rachel Howarth Misti McCain et al. | HCV Activates Somatic L1 Retrotransposition—A Potential Hepatocarcinogenesis Pathway | 2021 |
|
Dr Sam Tingle Dr Ibrahim Ibrahim Dr Emily Thompson Lucy Bates Dr Ashwin Sivaharan et al. | Methaemoglobinaemia Can Complicate Normothermic Machine Perfusion of Human Livers | 2021 |
|
Dr Sam Tingle Dr Emily Thompson Lucy Bates Dr Ibrahim Ibrahim Rodrigo Figueiredo et al. | Microvascular obstructions in portal bile duct capillaries and hepatic sinusoids during normothermic machine perfusion of marginal human livers | 2021 |
|
Dr Nicole Kattner Nicola Dyson Dr Yvonne Bury Dr Dina Tiniakos Tracey Davey et al. | Development and validation of a quantitative electron microscopy score to assess acute cellular stress in the human exocrine pancreas | 2020 |
|
Dr Ruchi Shukla Professor Helen Reeves Professor Stuart McPherson Misti McCain Dr Praveen Dhondurao Sudhindar et al. | Hepatitis C virus infection, endogenous retrotransposons activation and cancer risk | 2020 |
|
Dr Beate Haugk Dr Yvonne Bury
| Pancreatic pathology: where are we in 2019? | 2019 |
|
Professor Stuart McPherson Dr Nina Wilson Dr Dina Tiniakos Dr Jennifer Wilkinson Professor Alastair Burt et al. | A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis | 2017 |
|
Dr Beate Haugk Dr Yvonne Bury Dr Louise Coats Dr John O'Sullivan Dr Mark Hudson et al. | Defining the role of liver biopsy in the assessment of liver fibrosis in patients with Fontan circulation | 2017 |
|
Professor Colin Rees Dr Yvonne Bury
| Are there biological differences between screen-detected and interval colorectal cancers in the English Bowel Cancer Screening Programme? | 2016 |
|
Dr Dina Tiniakos Professor Quentin Anstee Professor Chris Day Professor Alastair Burt Dr John Brain et al. | Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference | 2016 |
|
Dr Dina Tiniakos Dr Yvonne Bury
| p62 (SQSTM1) expression in human liver disease: Preliminary results | 2015 |
|
Dr Dina Tiniakos Dr John Brain Dr Yvonne Bury
| Role of Histopathology in Autoimmune Hepatitis | 2015 |
|
Dr Yvonne Bury Naomi Brown Dr Dina Tiniakos
| p53 expression in human hepatocellular carcinoma (HCC): correlation with dysadherin expression and patient prognosis | 2014 |
|
David Bradburn Dr Yvonne Bury Professor Colin Rees
| Screen-detected colorectal cancers are associated with an improved outcome compared with stage-matched interval cancers | 2014 |
|
Dr Yvonne Bury
| The enhanced role of biomedical scientists in the histological dissection of axillary lymph node clearance specimens | 2014 |
|
Professor Pierre Bedossa Professor Alastair Burt Dr Dina Tiniakos Dr John Brain Dr Yvonne Bury et al. | Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease | 2014 |
|
Dr Dina Tiniakos Dr John Brain Dr Yvonne Bury
| Utility and appropriateness of the FLIP algorithm and SAF score in the evaluation of biopsies of nonalcoholic fatty liver disease. | 2014 |
|
Dr Nigel Kirkham Dr Yvonne Bury Dr Neelima Thampy
| A Structured Approach to the Diagnosis of Borderline Melanocytic Skin Lesions | 2013 |
|
Dr James Orr Dr Yvonne Bury Dr Mark Hudson Dr Steven Masson
| Liver transplantation for acute liver failure caused by macrophage activation syndrome | 2013 |
|
Dr Michael Bramble Dr Yvonne Bury Professor Colin Rees
| Screen-detected colorectal cancers are associated with an improved outcome when compared with interval cancers when matched for stage | 2013 |
|